Ann Janssens

7.4k total citations
100 papers, 1.5k citations indexed

About

Ann Janssens is a scholar working on Genetics, Pathology and Forensic Medicine and Hematology. According to data from OpenAlex, Ann Janssens has authored 100 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Genetics, 57 papers in Pathology and Forensic Medicine and 26 papers in Hematology. Recurrent topics in Ann Janssens's work include Chronic Lymphocytic Leukemia Research (65 papers), Lymphoma Diagnosis and Treatment (49 papers) and Platelet Disorders and Treatments (18 papers). Ann Janssens is often cited by papers focused on Chronic Lymphocytic Leukemia Research (65 papers), Lymphoma Diagnosis and Treatment (49 papers) and Platelet Disorders and Treatments (18 papers). Ann Janssens collaborates with scholars based in Belgium, United States and United Kingdom. Ann Janssens's co-authors include Fritz Offner, Jan Philippé, Lucien Noens, Bruce Poppe, Frank Speleman, Marc Bracke, Anne De Paepe, Heidi Van Limbergen, Barbara Vanhoecke and Sofie Lust and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Ann Janssens

96 papers receiving 1.5k citations

Peers

Countries citing papers authored by Ann Janssens

Since Specialization

Citations

This map shows the geographic impact of Ann Janssens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann Janssens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann Janssens more than expected).

Fields of papers citing papers by Ann Janssens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann Janssens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann Janssens. The network helps show where Ann Janssens may publish in the future.

Co-authorship network of co-authors of Ann Janssens

This figure shows the co-authorship network connecting the top 25 collaborators of Ann Janssens. A scholar is included among the top collaborators of Ann Janssens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann Janssens. Ann Janssens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	SINGLE-AGENT EPCORITAMAB LEADS TO DEEP RESPONSES IN PATIENTS (PTS) WITH RICHTER’S TRANSFORMATION (RT): PRIMARY RESULTS FROM THE EPCORE CLL-1 TRIAL 2024 ·University of Southern Denmark Research Portal (University of Southern Denmark) ·Arnon P. Kater, Ann Janssens, Herbert Eradat, Fritz Offner, (unknown), Mazyar Shadman, Christian Bjørn Poulsen, Jacob Haaber Christensen, Meghan C. Thompson, (unknown), А. А. Кузнецова, Toshihiko Oki, Rebecca Valentin, Mar Bellido, (unknown)	1
2	Epcoritamab Induces Deep Responses in Patients With Richter Transformation (RT): Primary Results From the EPCORE CLL-1 Trial 2024 ·Clinical Lymphoma Myeloma & Leukemia ·Arnon P. Kater, Ann Janssens, Herbert Eradat, Fritz Offner, Jose Sandoval‐Sus, Mazyar Shadman, Christian Bjørn Poulsen, Jacob Haaber Christensen, Meghan C. Thompson, (unknown), А. А. Кузнецова, Toshihiko Oki, Rebecca Valentin, Mar Bellido, (unknown)	2
3	[¹⁸F]FDG-PET/CT volumetric parameters can predict outcome in untreated mantle cell lymphoma 2022 ·Leukemia & lymphoma ·(unknown), Gregor Verhoef, Ann Janssens, Feng Jung Sherida H. Woei-A-Jin, Annouschka Laenen, Thomas Tousseyn, Daan Dierickx, Christophe M. Deroose	7
4	Quantitative Whole-Body Diffusion-weighted MRI after One Treatment Cycle for Aggressive Non-Hodgkin Lymphoma Is an Independent Prognostic Factor of Outcome 2021 ·Radiology Imaging Cancer ·(unknown), (unknown), Giorgio Maria Agazzi, Frederik De Keyzer, Olivier Gheysens, Oliver Bechter, Pascal Wolter, Daan Dierickx, Ann Janssens, Gregor Verhoef, Raymond Oyen, Michel Koole, Vincent Vandecaveye	2
5	PF494 CLINICAL OUTCOMES WITH SINGLE‐AGENT IBRUTINIB FOR RELAPSED/REFRACTORY (R/R) MANTLE CELL LYMPHOMA (MCL): INTERIM ANALYSIS (IA) OF THE BELGIAN IBRUTINIB REAL‐WORLD DATA (BIRD) STUDY 2019 ·HemaSphere ·Ann Janssens, Z. N. Berneman, Dominique Bron, Sylvia Snauwaert, (unknown), (unknown), (unknown), Robert Wapenaar, (unknown)	0
6	IBRUTINIB PLUS BENDAMUSTINE AND RITUXIMAB IN PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA (CLL/SLL): 2-YEAR FOLLOW-UP INCLUDING MRD FROM THE HELIOS STUDY 2016 ·Haematologica ·Graeme Fraser, Paula Cramer, Fatih Demırkan, (unknown), Sebastian Grosicki, Ann Janssens, Jiřı́ Mayer, Marie‐Sarah Dilhuydy, Halyna Pylypenko, Javier Loscertales, André Goy, Abraham Avigdor, (unknown), Charles E. Phelps, Michelle Mahler, Mariya Salman, Angela Howes, Michael Hallek	4
7	BHS Guidelines for the treatment of Burkitt’s lymphoma 2015 ·Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)) ·Christophe Bonnet, Ann Janssens, (unknown), (unknown), (unknown), (unknown), Thomas Tousseyn, Marc André, Dominique Bron, Ambro van Hoof, G. Verhoef, Bernard De Prijck, Yves Béguin, Daan Dierickx	5
8	INTERIM RESULTS FROM A PHASE IIA STUDY OF THE ANTI-CXCL12 SPIEGELMER OLAPTESED PEGOL (NOX-A12) IN COMBINATION WITH BENDAMUSTINE/RITUXIMAB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA 2014 ·Haematologica ·Michael Steurer, Lydia Scarfò, Marco Montillo, Ann Janssens, Sophie Wildner, Francesca Romana Mauro, Livio Trentin, J. Thaler, Sonja Burgstaller, Anna Kruschinski, (unknown), (unknown), Paolo Ghia, Federico Caligaris‐Cappio, Marco Gobbi	2
9	Characteristics, treatment and prognosis of primary central nervous system lymphoma: a single center retrospective study 2014 ·Acta Clinica Belgica ·Daan Dierickx, (unknown), (unknown), Gregor Verhoef, Paul M. Clément, Philippe Demaerel, Thomas Tousseyn, Michel Delforge, Timothy Devos, Ann Janssens, Johan Maertens, Hélène Schoemans	1
10	SF3B1 mutations and outcome in CLL patients treated with chlorambucil (CHL) or ofatumumab-CHL (O plus CHL): results from the phase III study complement 1 (OMB110911) 2014 ·Haematologica ·Eugen Tausch, (unknown), R. Schlenk, Peter Hillmen, Fritz Offner, Ann Janssens, (unknown), Sebastian Grosicki, Jiřı́ Mayer, (unknown), Astrid McKeown, (unknown), (unknown), Hartmut Döhner, S. Stilgenbauer	1
11	BHS guidelines for the treatment of marginal zone lymphomas 2014 ·Open Repository and Bibliography (University of Liège) ·Dominique Bron, Éric Van Den Neste, Alain Kentos, Fritz Offner, Wilfried Schroyens, Christophe Bonnet, Ambro van Hoof, G. Verhoef, Ann Janssens	2
12	Ofatumumab + Chlorambucil Versus Chlorambucil Alone In Patients With Untreated Chronic Lymphocytic Leukemia (CLL): Results Of The Phase III Study Complement 1 (OMB110911) 2013 ·Blood ·Peter Hillmen, Tadeusz Robak, Ann Janssens, (unknown), Sebastian Grosicki, Jiřı́ Mayer, Panagiotis Panagiotidis, Eva Kimby, Anna Schuh, Thomas E. Boyd, Marco Montillo, Astrid McKeown, Jodi Carey, Ira Gupta, Chai‐Ni Chang, Steen Lisby, Fritz Offner	58
13	Treatment of peripheral T-cell lymphomas: recommendations of the Belgian Hematological Society (BHS). 2013 ·Open Repository and Bibliography (University of Liège) ·(unknown), Ambro van Hoof, (unknown), Daan Dierickx, Virginie De Wilde, Fritz Offner, (unknown), Anne Sonet, (unknown), Ann Janssens, Christophe Bonnet, Bernard De Prijck, Pierre Zachée, Alain Kentos, (unknown), Éric Van Den Neste	0
14	Primary immune thrombocytopenia in adults 2013 ·Open Repository and Bibliography (University of Liège) ·Ann Janssens, Catherine Lambert, (unknown), André Bosly, Dominik Selleslag, Yves Béguin	1
15	Guidelines for newly diagnosed diffuse large B-cell lymphoma (DLBCL) and relapsed DLBCL 2013 ·Open Repository and Bibliography (University of Liège) ·G. Verhoef, Wilfried Schroyens, Dominique Bron, Christophe Bonnet, Virginie De Wilde, Ambro van Hoof, Ann Janssens, Daan Dierickx, Marc André, Éric Van Den Neste	2
16	Guidelines of the Belgian hamatological Society for newly diagnosed and relapsed follicular lymphoma 2012. 2012 ·Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)) ·(unknown), Ambro van Hoof, Anne Sonet, Christophe Bonnet, Ann Janssens, G. Verhoef, Daan Dierickx, Virginie De Wilde, Dominique Bron, (unknown), Éric Van Den Neste, Fritz Offner	1
17	Monoclonal antibody fluorescence for blasts detection, quantification and lineage identification with an automated hematology analyser Abbott-CELL-DYN Sapphire: comparison with flow cytometry and morphology 2008 ·International Journal of Laboratory Hematology ·Brigitte Cantinieaux, (unknown), Ann Janssens, (unknown), Dominique Bron, (unknown)	1
18	Rituximab therapy for immune-mediated hematological disorders: A Belgian multi-center project 2007 ·Acta Clinica Belgica ·Daan Dierickx, Ann Janssens, Gregor Verhoef, (unknown), (unknown), Alina Ferster, (unknown), (unknown), (unknown), Yves Béguin, C. Vermylen, (unknown)	2
19	In Vitro Screening for Synergism of High-Linear Energy Transfer ²¹³ Bi-Radiotherapy with Other Therapeutic Agents for the Treatment of B-Cell Chronic Lymphocytic Leukemia 2006 ·Cancer Biotherapy and Radiopharmaceuticals ·(unknown), Hubert Thierens, Filip De Vos, Jan Philippé, Fritz Offner, Ann Janssens, Christos Apostolidis, Aliyah Morgenstern, Klaus Bacher, (unknown), Rudi Dierckx, Guido Slegers	1
20	Correlation of ZAP-70 analysed by flow cytometry with IgVH mutational status in B-CLL 2004 ·Ghent University Academic Bibliography (Ghent University) ·Jan Philippé, (unknown), (unknown), Femke Van Bockstaele, Ann Janssens, Fritz Offner	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact